Pharmacokinetics of prednisolone at steady state in young patients with systemic lupus erythematosus on prednisone therapy: an open-label, single-dose study.
about
The Use of Gene Ontology Term and KEGG Pathway Enrichment for Analysis of Drug Half-LifeExposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritisManagement considerations for childhood-onset systemic lupus erythematosus patients and implications on therapy.Should we stop dosing steroids per body surface area for nephrotics?
P2860
Pharmacokinetics of prednisolone at steady state in young patients with systemic lupus erythematosus on prednisone therapy: an open-label, single-dose study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 October 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetics of prednisolo ...... open-label, single-dose study.
@en
Pharmacokinetics of prednisolo ...... open-label, single-dose study.
@nl
type
label
Pharmacokinetics of prednisolo ...... open-label, single-dose study.
@en
Pharmacokinetics of prednisolo ...... open-label, single-dose study.
@nl
prefLabel
Pharmacokinetics of prednisolo ...... open-label, single-dose study.
@en
Pharmacokinetics of prednisolo ...... open-label, single-dose study.
@nl
P2093
P2860
P1476
Pharmacokinetics of prednisolo ...... open-label, single-dose study
@en
P2093
Anna Carmela P Sagcal-Gironella
Hermine I Brunner
Michael J Rieder
Rommel G Tirona
P2860
P304
P356
10.1016/J.CLINTHERA.2011.09.015
P577
2011-10-07T00:00:00Z